BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10712925)

  • 21. SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling.
    Bai RY; Koester C; Ouyang T; Hahn SA; Hammerschmidt M; Peschel C; Duyster J
    Nat Cell Biol; 2002 Mar; 4(3):181-90. PubMed ID: 11836524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal.
    Watanabe M; Masuyama N; Fukuda M; Nishida E
    EMBO Rep; 2000 Aug; 1(2):176-82. PubMed ID: 11265759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-{beta} superfamily of cytokines.
    Pan D; Estévez-Salmerón LD; Stroschein SL; Zhu X; He J; Zhou S; Luo K
    J Biol Chem; 2005 Apr; 280(16):15992-6001. PubMed ID: 15647271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The smad proteins and TGFbeta signalling: uncovering a pathway critical in cancer.
    Rooke HM; Crosier KE
    Pathology; 2001 Feb; 33(1):73-84. PubMed ID: 11280614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads.
    Burton T; Liang B; Dibrov A; Amara F
    Biochem Biophys Res Commun; 2002 Jul; 295(3):713-23. PubMed ID: 12099698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.
    Lee HJ; Lee JK; Miyake S; Kim SJ
    J Biol Chem; 2004 Jan; 279(4):2666-72. PubMed ID: 14612439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new partner for inhibitory Smads.
    Miyazono K
    Cytokine Growth Factor Rev; 2002 Feb; 13(1):7-9. PubMed ID: 11750875
    [No Abstract]   [Full Text] [Related]  

  • 28. TGF-beta signaling by Smad proteins.
    Miyazono K; ten Dijke P; Heldin CH
    Adv Immunol; 2000; 75():115-57. PubMed ID: 10879283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone.
    Wurthner JU; Frank DB; Felici A; Green HM; Cao Z; Schneider MD; McNally JG; Lechleider RJ; Roberts AB
    J Biol Chem; 2001 Jun; 276(22):19495-502. PubMed ID: 11278302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation.
    Izzi L; Attisano L
    Oncogene; 2004 Mar; 23(11):2071-8. PubMed ID: 15021894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
    Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
    Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
    J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
    Kahata K; Hayashi M; Asaka M; Hellman U; Kitagawa H; Yanagisawa J; Kato S; Imamura T; Miyazono K
    Genes Cells; 2004 Feb; 9(2):143-51. PubMed ID: 15009097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Smads: transcriptional regulation and mouse models.
    Datto M; Wang XF
    Cytokine Growth Factor Rev; 2000; 11(1-2):37-48. PubMed ID: 10708951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
    Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
    J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signalling pathway.
    Ohta S; Takeuchi M; Deguchi M; Tsuji T; Gahara Y; Nagata K
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):395-404. PubMed ID: 10947953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
    Lin X; Liang M; Feng XH
    J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.